[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @monaco_biotech Monaco Several biopharmaceutical companies have recently made announcements regarding clinical trials, partnerships, and financial offerings. Notably, companies such as Atai Life Sciences, Praxis Precision Medicines, and Rapt Therapeutics have announced public offerings, while others like Summit Therapeutics and Regeneron have shared updates on their oncology portfolios and pipeline advancements. Additionally, companies like Viridian Therapeutics and Cargo Therapeutics have made announcements regarding public offerings and acquisitions. ### Engagements: XXXXXX [#](/creator/twitter::1285320477439860737/interactions)  - X Week XXXXXX +56% - X Month XXXXXXX -XX% - X Months XXXXXXXXX +157% - X Year XXXXXXXXX +40% ### Mentions: XX [#](/creator/twitter::1285320477439860737/posts_active)  - X Week XXX -XX% - X Month XXX -XX% - X Months XXXXX +41% - X Year XXXXX +12% ### Followers: XXXXX [#](/creator/twitter::1285320477439860737/followers)  - X Week XXXXX +0.36% - X Month XXXXX +3.30% - X Months XXXXX +39% - X Year XXXXX +64% ### CreatorRank: XXXXXXX [#](/creator/twitter::1285320477439860737/influencer_rank)  ### Social Influence **Social category influence** [countries](/list/countries) XXXXX% [stocks](/list/stocks) XXXXX% [cryptocurrencies](/list/cryptocurrencies) XXXX% [finance](/list/finance) XXXX% [currencies](/list/currencies) XXXX% **Social topic influence** [$prax](/topic/$prax) 3.27%, [$asnd](/topic/$asnd) 3.27%, [$kymr](/topic/$kymr) #25, [kymera](/topic/kymera) #9, [announces](/topic/announces) 2.61%, [$tara](/topic/$tara) #46, [$gpcr](/topic/$gpcr) #10, [$adct](/topic/$adct) #5, [$bhvn](/topic/$bhvn) 1.96%, [$nuvl](/topic/$nuvl) XXXX% **Top accounts mentioned or mentioned by** [@aaronrosenblum5](/creator/undefined) [@justiceforb_md](/creator/undefined) [@seedy19tron](/creator/undefined) [@saicharanaitha](/creator/undefined) [@karensmithfl](/creator/undefined) [@threadanddoc](/creator/undefined) [@rezfszubagoly](/creator/undefined) [@joserestonva](/creator/undefined) [@oncinvestor](/creator/undefined) [@andre_agtc](/creator/undefined) [@pencilvester999](/creator/undefined) [@biopharmacaster](/creator/undefined) [@biotechport](/creator/undefined) [@senormargarita](/creator/undefined) [@jeremyj0916](/creator/undefined) [@tuduni90782](/creator/undefined) [@tallnfat](/creator/undefined) [@svarre001](/creator/undefined) [@biohazard3737](/creator/undefined) [@snupsnus](/creator/undefined) **Top assets mentioned** [Praxis Precision Medicines, Inc. Common Stock (PRAX)](/topic/$prax) [Kymera Therapeutics, Inc. Common Stock (KYMR)](/topic/$kymr) [Taraxa (TARA)](/topic/$tara) [ADC Therapeutics SA (ADCT)](/topic/$adct) [Biohaven Pharmaceutical Holding Company Ltd. (BHVN)](/topic/$bhvn) [Nuvalent, Inc. Class A Common Stock (NUVL)](/topic/$nuvl) [Biogen Inc (BIIB)](/topic/$biib) [Dyne Therapeutics, Inc. Common Stock (DYN)](/topic/$dyn) [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [Cogent Biosciences, Inc. Common Stock (COGT)](/topic/$cogt) [Neurocrine Biosciences, Inc. (NBIX)](/topic/$nbix) [United Therapeutics, Corp. (UTHR)](/topic/$uthr) [Arrowhead Research Corporation (ARWR)](/topic/$arwr) [Vera Therapeutics, Inc. Class A Common Stock (VERA)](/topic/$vera) [Ionis Pharmaceuticals, Inc. Common Stock (IONS)](/topic/$ions) [SATS (Ordinals) (SATS)](/topic/$sats) [Mirum Pharmaceuticals, Inc. Common Stock (MIRM)](/topic/$mirm) [Wave Life Sciences Ltd. Ordinary Shares (WVE)](/topic/$wve) [Terns Pharmaceuticals, Inc. Common Stock (TERN)](/topic/$tern) [Royalty Pharma plc Class A Ordinary Shares (RPRX)](/topic/$rprx) [Denali Therapeutics Inc. Common Stock (DNLI)](/topic/$dnli) [Liquidia Corporation Common Stock (LQDA)](/topic/$lqda) [Krystal Biotech, Inc. Common Stock (KRYS)](/topic/$krys) [Axsome Therapeutics, Inc (AXSM)](/topic/$axsm) [Madrigal Pharmaceuticals, Inc. Common Stock (MDGL)](/topic/$mdgl) [Akropolis (AKRO)](/topic/$akro) [Prothena Corporation plc Ordinary Shares (PRTA)](/topic/$prta) [CG Oncology, Inc. Common stock (CGON)](/topic/$cgon) [Insmed, Inc. (INSM)](/topic/$insm) [uniQure N.V. (QURE)](/topic/$qure) [Avidity Biosciences, Inc. Common Stock (RNA)](/topic/$rna) [Veeva Systems, Inc. (VEEV)](/topic/$veev) [Dawn Protocol (DAWN)](/topic/$dawn) [AltLayer (ALT)](/topic/$alt) [AstraZeneca PLC (AZN)](/topic/$azn) [IDEAYA Biosciences, Inc. Common Stock (IDYA)](/topic/$idya) [Xenon Pharmaceuticals Inc (XENE)](/topic/$xene) [Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX)](/topic/$rxrx) ### Top Social Posts Top posts by engagements in the last XX hours "$SATS frisky 🔥 Not a bio but it might be worth risking a trade" [X Link](https://x.com/monaco_biotech/status/1997848806474543414) 2025-12-08T02:00Z 6154 followers, 1157 engagements "@biopharmacaster Patience. People have to realize these amazing results $DYN. $SRPT should be toast on this news" [X Link](https://x.com/monaco_biotech/status/1997996097952727118) 2025-12-08T11:46Z 6157 followers, 1004 engagements "$ABOS Acumen Pharmaceuticals Highlights Enhanced Brain Delivery Technology for Oligomer-Selective Antibod. - ABOS BioPharmCatalyst" [X Link](https://x.com/monaco_biotech/status/1995845912870965360) 2025-12-02T13:22Z 6154 followers, 1055 engagements "@SaicharanAitha Yes" [X Link](https://x.com/monaco_biotech/status/1997845921359696152) 2025-12-08T01:49Z 6154 followers, XXX engagements "$MIRM Mirum Pharmaceuticals Enters into Definitive Agreement to Acquire Bluejay Therapeutics Expanding Global Leadership in Rare Disease BioPharmCatalyst" [X Link](https://x.com/monaco_biotech/status/1998017151483969807) 2025-12-08T13:09Z 6157 followers, 1194 engagements "Brief recap of my long tickets today. All sold with data spike today: $IMMX +11% 📈 $FULC +62% 📈 $DYN +15% 📈 $GPCR +150% 📈 * $WVE +158% 📈 $TERN +35% 📈 * Unfortunately sold a little too early. I'm not a fan of having too many stocks in my longterm port so I'm waiting for the financings and then picking out 1-2 gems. $GPCR is definitely one of them" [X Link](https://x.com/monaco_biotech/status/1998131942659629074) 2025-12-08T20:45Z 6157 followers, 4927 engagements "$RPRX $DNLI Denali Therapeutics and Royalty Pharma Announce $XXX Million Royalty Funding Agreement BioPharmCatalyst" [X Link](https://x.com/monaco_biotech/status/1996554441558806936) 2025-12-04T12:17Z 6154 followers, 1556 engagements "$KYMR Kymera Therapeutics Announces Proposed Public Offering BioPharmCatalyst" [X Link](https://x.com/monaco_biotech/status/1998136294145495200) 2025-12-08T21:03Z 6157 followers, 2193 engagements "$PRAX Praxis AES Wrap-up: Best-in-Class Potential Across Rare Pediatric and Adult Epilepsies BioPharmCatalyst" [X Link](https://x.com/monaco_biotech/status/1998018358445322340) 2025-12-08T13:14Z 6157 followers, 1582 engagements "$COGT I have added to my existing long-term position. I am deeply convinced that this stock is a candidate for a buyout that at least 2-3 big pharma will be fighting over. Thanks for the dips. I will continue to accumulate ✌🏻🤑" [X Link](https://x.com/monaco_biotech/status/1998457859290341480) 2025-12-09T18:20Z 6157 followers, 9789 engagements "$RGNX REGENXBIO Presents Positive Twelve-Month Pivotal Data from Phase I/II/III CAMPSIITE Trial of RGX-12. - RGNX BioPharmCatalyst" [X Link](https://x.com/monaco_biotech/status/1963922093684244708) 2025-09-05T11:08Z 6155 followers, 1438 engagements "$NBIX Neurocrine Biosciences Presents New Three-Year Data Demonstrating Sustained Clinical Benefits and Es. - NBIX BioPharmCatalyst" [X Link](https://x.com/monaco_biotech/status/1975177619483050184) 2025-10-06T12:33Z 6153 followers, 3233 engagements "$ASND Ascendis Submits Marketing Authorisation Application to the European Medicines Agency for TransCon. - ASND BioPharmCatalyst" [X Link](https://x.com/monaco_biotech/status/1976015269697818882) 2025-10-08T20:02Z 6146 followers, 1730 engagements "$KYMR Kymera Therapeutics Presents New Preclinical Data for KT-579 a First-in-Class Oral IRF5 Degrader. - KYMR BioPharmCatalyst" [X Link](https://x.com/monaco_biotech/status/1982768229727555918) 2025-10-27T11:15Z 6156 followers, 1148 engagements "$SLS SELLAS Life Sciences Group Announces Exercise of Existing Warrants Held by a Current Institutional I. - SLS BioPharmCatalyst" [X Link](https://x.com/monaco_biotech/status/1982789090408796518) 2025-10-27T12:38Z 6147 followers, 1536 engagements "$UTHR United Therapeutics Corporation Reports Record Third Quarter 2025 Financial Results - UTHR BioPharmCatalyst" [X Link](https://x.com/monaco_biotech/status/1983482231290003708) 2025-10-29T10:33Z 6146 followers, 5557 engagements "I took X new trading positions in $LQDA $KRYS and $AXSM. All X have earnings calls on Monday before market open" [X Link](https://x.com/monaco_biotech/status/1984284359302795594) 2025-10-31T15:40Z 6146 followers, 8088 engagements "$ARWR $KURA $ASND" [X Link](https://x.com/monaco_biotech/status/1984344405508321323) 2025-10-31T19:39Z 6146 followers, 4819 engagements "$MDGL delivered again solid numbers. Sold today my position @ 460$. I don't think this price can be maintained especially not in this market jmho" [X Link](https://x.com/monaco_biotech/status/1985805710207131733) 2025-11-04T20:25Z 6146 followers, 4141 engagements "$VERA Vera Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results - VERA BioPharmCatalyst" [X Link](https://x.com/monaco_biotech/status/1986053911589912730) 2025-11-05T12:52Z 6146 followers, XXX engagements "$VERA Vera Therapeutics Announces Positive ORIGIN Phase X Data for Atacicept in IgA Nephropathy Presented. - VERA BioPharmCatalyst" [X Link](https://x.com/monaco_biotech/status/1986446725582614699) 2025-11-06T14:53Z 6146 followers, 1206 engagements "$ASND New Pooled 3-Year Analysis Confirms Sustained Clinically Meaningful Improvements in Renal Function. - ASND BioPharmCatalyst" [X Link](https://x.com/monaco_biotech/status/1986788936539083055) 2025-11-07T13:32Z 6146 followers, 1138 engagements "$ADCT ADC Therapeutics Reports Third Quarter 2025 Financial Results and Provides Operational Update - ADCT BioPharmCatalyst" [X Link](https://x.com/monaco_biotech/status/1987863758794788930) 2025-11-10T12:43Z 6151 followers, XXX engagements "$NBIX #fail Neurocrine Biosciences Provides Update on Phase X Study of NBI-1070770 in Adults with Major Depressi. - NBIX BioPharmCatalyst" [X Link](https://x.com/monaco_biotech/status/1987991277183660464) 2025-11-10T21:10Z 6152 followers, 10.7K engagements "$QNCX +15% 📈 AH Quince Therapeutics Announces Positive iDSMB Review for eDSP in Pivotal Phase X NEAT Clinical Trial. - QNCX BioPharmCatalyst" [X Link](https://x.com/monaco_biotech/status/1987991775903195256) 2025-11-10T21:12Z 6145 followers, 1064 engagements "$PRTA Prothena Highlights Phase X Data for Coramitug (Formerly PRX004) Published in Circulation Official. - PRTA BioPharmCatalyst" [X Link](https://x.com/monaco_biotech/status/1988249081198588206) 2025-11-11T14:14Z 6146 followers, 1928 engagements "$BHVN Biohaven Announces Proposed Public Offering of Common Shares - BHVN BioPharmCatalyst" [X Link](https://x.com/monaco_biotech/status/1988352897327804701) 2025-11-11T21:07Z 6145 followers, 2636 engagements "$ASND Ascendis Pharma Reports Third Quarter 2025 Financial Results - ASND BioPharmCatalyst" [X Link](https://x.com/monaco_biotech/status/1988713808114680132) 2025-11-12T21:01Z 6145 followers, 1130 engagements "$CGON CG Oncology Reports Third Quarter 2025 Financial Results and Provides Business Updates - CGON BioPharmCatalyst" [X Link](https://x.com/monaco_biotech/status/1989322344939020414) 2025-11-14T13:19Z 6153 followers, XXX engagements "There is only one new 13-F that really interests me: DARWIN GLOBAL MANAGEMENT LTD $ABVX $INSM $UTHR $QURE" [X Link](https://x.com/monaco_biotech/status/1989471255347826895) 2025-11-14T23:11Z 6152 followers, 33K engagements "$NUVL Nuvalent Announces Positive Topline Pivotal Data from ALKOVE-1 Clinical Trial of Neladalkib for TKI. - NUVL BioPharmCatalyst" [X Link](https://x.com/monaco_biotech/status/1990382570203238531) 2025-11-17T11:32Z 6146 followers, 1832 engagements "Added a new position $BHVN here. Set and forget" [X Link](https://x.com/monaco_biotech/status/1990503089523093798) 2025-11-17T19:31Z 6145 followers, 13.9K engagements "$NUVL Nuvalent Announces Public Offering of Common Stock - NUVL BioPharmCatalyst" [X Link](https://x.com/monaco_biotech/status/1990526009805058158) 2025-11-17T21:02Z 6146 followers, 1157 engagements "$ASND Results of Pivotal ApproaCH Trial of TransCon CNP (Navepegritide) in Children with Achondroplasia P. - ASND BioPharmCatalyst" [X Link](https://x.com/monaco_biotech/status/1990526379197092050) 2025-11-17T21:04Z 6146 followers, 3669 engagements "$TARA Conference call and live webcast at 8:30 a.m. ET on Wednesday November XX 2025 📌 Protara Therapeutics to Host Conference Call and Webcast to Review New Interim Data from Phase X STA. - TARA BioPharmCatalyst" [X Link](https://x.com/monaco_biotech/status/1990896037817692516) 2025-11-18T21:32Z 6151 followers, 2309 engagements "$BHVN UP 📈" [X Link](https://x.com/monaco_biotech/status/1990921668135456919) 2025-11-18T23:14Z 6145 followers, 6863 engagements "$NUVL @ $XXXXXX Nuvalent Announces Pricing of Public Offering of Common Stock" [X Link](https://x.com/monaco_biotech/status/1991070041173864776) 2025-11-19T09:04Z 6146 followers, 1241 engagements "$RNA Avidity Biosciences Announces U.S. Managed Access Program (MAP) for Investigational Therapy del-zota. - RNA BioPharmCatalyst" [X Link](https://x.com/monaco_biotech/status/1991148241249779954) 2025-11-19T14:15Z 6153 followers, 1632 engagements "$VEEV $RHHBF Veeva Announces Expanded Partnership with Roche" [X Link](https://x.com/monaco_biotech/status/1992930190624719290) 2025-11-24T12:15Z 6151 followers, 1163 engagements "$BIIB Biogen and Dayra Therapeutics Announce Research Collaboration to Discover and Develop Oral Macrocycl. - BIIB BioPharmCatalyst" [X Link](https://x.com/monaco_biotech/status/1992934054992232865) 2025-11-24T12:31Z 6150 followers, XXX engagements "$ARWR $SRPT Arrowhead Pharmaceuticals Earns $XXX Million Milestone Payment from Sarepta Therapeutics - SRPT BioPharmCatalyst" [X Link](https://x.com/monaco_biotech/status/1992939578114670759) 2025-11-24T12:53Z 6150 followers, 1518 engagements "$DAWN Day One Announces Three Year Follow-Up Data From OJEMDA (tovorafenib) Phase X FIREFLY-1 Trial at th. - DAWN BioPharmCatalyst" [X Link](https://x.com/monaco_biotech/status/1992946002366534001) 2025-11-24T13:18Z 6150 followers, 1399 engagements "$BIIB Eisai Completes Rolling Submission to U.S. FDA for LEQEMBI IQLIK (lecanemab-irmb) Supplemental Bio. - BIIB BioPharmCatalyst" [X Link](https://x.com/monaco_biotech/status/1993296789928046773) 2025-11-25T12:32Z 6151 followers, 1142 engagements "$QTTB Q32 Bio Sells Complement Inhibitor ADX-097" [X Link](https://x.com/monaco_biotech/status/1995463721401852308) 2025-12-01T12:03Z 6152 followers, 5014 engagements "$IONS Ionis receives U.S. FDA Breakthrough Therapy designation for olezarsen for severe hypertriglyceridem. - IONS BioPharmCatalyst" [X Link](https://x.com/monaco_biotech/status/1995464213343383857) 2025-12-01T12:05Z 6146 followers, 1066 engagements "$ALT Altimmune Announces CEO Transition and Succession Plan - ALT BioPharmCatalyst" [X Link](https://x.com/monaco_biotech/status/1995470629600928085) 2025-12-01T12:30Z 6144 followers, 1454 engagements "$TARA Protara Therapeutics to Host Conference Call and Webcast to Review New Interim Data from Phase X ADV. - TARA BioPharmCatalyst" [X Link](https://x.com/monaco_biotech/status/1995606197463142456) 2025-12-01T21:29Z 6151 followers, 2055 engagements "$FENC Fennec Pharmaceuticals Announces Positive Topline Results From Investigator-Initiated Clinical Study. - FENC BioPharmCatalyst" [X Link](https://x.com/monaco_biotech/status/1995829008907321407) 2025-12-02T12:14Z 6155 followers, XXX engagements "$IONS Ionis receives U.S. FDA Breakthrough Therapy designation for zilganersen for Alexander disease (AxD) - IONS BioPharmCatalyst" [X Link](https://x.com/monaco_biotech/status/1995829084593516694) 2025-12-02T12:15Z 6146 followers, 1070 engagements "$BAYRY Bayer Starts New Phase III Study with Mirena for the Treatment of Nonatypical Endometrial Hyperplas. - BAYRY BioPharmCatalyst" [X Link](https://x.com/monaco_biotech/status/1995848604615905289) 2025-12-02T13:32Z 6146 followers, 1012 engagements "$AZN Baxdrostat New Drug Application accepted under FDA Priority Review in the US for patients with hard-. - AZN BioPharmCatalyst @avidresearch" [X Link](https://x.com/monaco_biotech/status/1995860157960429773) 2025-12-02T14:18Z 6153 followers, 1616 engagements "$ADCT Company to host corporate webcast to share updated data on December X 2025 📌 ADC Therapeutics to Provide Update on LOTIS-7 Clinical Trial - ADCT BioPharmCatalyst" [X Link](https://x.com/monaco_biotech/status/1995968508492931154) 2025-12-02T21:29Z 6151 followers, 1483 engagements "$BIIB New Data Presented at the Clinical Trials on Alzheimer's Disease (CTAD) Conference 2025 Confirms Pha. - BIIB BioPharmCatalyst" [X Link](https://x.com/monaco_biotech/status/1995971735720505611) 2025-12-02T21:41Z 6150 followers, 1279 engagements "$ADCT ADC Therapeutics Announces Updated Data from LOTIS-7 Phase 1b Clinical Trial of ZYNLONTA in Combina. - ADCT BioPharmCatalyst" [X Link](https://x.com/monaco_biotech/status/1996197600509256020) 2025-12-03T12:39Z 6151 followers, 1443 engagements "$PRAX Praxis Precision Medicines Announces Positive Pre-NDA Meeting with FDA for Ulixacaltamide in Essential Tremor BioPharmCatalyst" [X Link](https://x.com/monaco_biotech/status/1996687044010250319) 2025-12-04T21:04Z 6150 followers, 7592 engagements "$PRAX Praxis Precision Medicines Announces Positive Results from EMBOLD Study for Relutrigine in SCN2A and SCN8A Developmental and Epileptic Encephalopathies BioPharmCatalyst" [X Link](https://x.com/monaco_biotech/status/1996689802683441621) 2025-12-04T21:15Z 6146 followers, 2873 engagements "$PRAX baby 🚀" [X Link](https://x.com/monaco_biotech/status/1996694509216833733) 2025-12-04T21:34Z 6146 followers, 4570 engagements "$IDYA IDE034 a Bispecific ADC Licensed by Biocytogen to IDEAYA Receives FDA IND Clearance BioPharmCatalyst" [X Link](https://x.com/monaco_biotech/status/1996732619145334914) 2025-12-05T00:05Z 6151 followers, 1711 engagements "$XENE Xenon Showcases New 48-Month Azetukalner OLE Study Data in Epilepsy at AES 2025 BioPharmCatalyst" [X Link](https://x.com/monaco_biotech/status/1996947474892603480) 2025-12-05T14:19Z 6151 followers, XXX engagements "$KYMR Kymera Therapeutics to Announce KT-621 BroADen Phase 1b Atopic Dermatitis Trial Results on December X 2025 BioPharmCatalyst @seedy19tron" [X Link](https://x.com/monaco_biotech/status/1997144111103574069) 2025-12-06T03:20Z 6155 followers, 2429 engagements "$SLS SELLAS Life Sciences Presents Positive Phase X Data of SLS009 in Combination with AZA/VEN in Relapsed/Refractory AML-MR at ASH 2025 BioPharmCatalyst" [X Link](https://x.com/monaco_biotech/status/1997804659453427838) 2025-12-07T23:05Z 6155 followers, 2541 engagements "$KYMR Kymera Therapeutics Announces Positive Results from BroADen Phase 1b Clinical Trial of KT-621 a First-in-Class Oral STAT6 Degrader in Patients with Moderate to Severe Atopic Dermatitis BioPharmCatalyst" [X Link](https://x.com/monaco_biotech/status/1998000653629607977) 2025-12-08T12:04Z 6155 followers, 1577 engagements "$RXRX Positive Phase 1b/2 Results from Ongoing REC-4881 TUPELO Trial Demonstrate Rapid and Durable Reductions in Polyp Burden in Familial Adenomatous Polyposis (FAP) at XX Weeks" [X Link](https://x.com/monaco_biotech/status/1998008071017103837) 2025-12-08T12:33Z 6153 followers, 1116 engagements "$RGNX REGENXBIO Announces FDA Review Extension of BLA for RGX-121 to Treat Patients with MPS II" [X Link](https://x.com/monaco_biotech/status/1957548885464715677) 2025-08-18T21:03Z 6154 followers, 2773 engagements "$TARA Protara Therapeutics Announces Positive Interim Results Demonstrating Robust Responses in the Ongoin. - TARA BioPharmCatalyst" [X Link](https://x.com/monaco_biotech/status/1991131551506043233) 2025-11-19T13:08Z 6154 followers, 2487 engagements "$TARA Protara Announces Proposed Public Offering BioPharmCatalyst" [X Link](https://x.com/monaco_biotech/status/1996692596375408824) 2025-12-04T21:26Z 6154 followers, 1075 engagements "$SABS SAB BIO to Present Data Showcasing Progress in the Development of SAB-142 at the Asian Conference on Innovative Therapies for Diabetes Management BioPharmCatalyst" [X Link](https://x.com/monaco_biotech/status/1998017654284546468) 2025-12-08T13:11Z 6157 followers, 1230 engagements "@lame_karma Congrats. Now that the binaries are done it's time to see who has the most buyout potential. Not an easy task but I see $GPCR at the top of the list. $COGT too. And I agree that $FULC also belong in the inner circle. Too many good names at the moment" [X Link](https://x.com/monaco_biotech/status/1998174650157977993) 2025-12-08T23:35Z 6157 followers, XXX engagements "$LXEO Added today new trading position for data event soon" [X Link](https://x.com/monaco_biotech/status/1998462000003760174) 2025-12-09T18:37Z 6157 followers, 2761 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@monaco_biotech Monaco
Several biopharmaceutical companies have recently made announcements regarding clinical trials, partnerships, and financial offerings. Notably, companies such as Atai Life Sciences, Praxis Precision Medicines, and Rapt Therapeutics have announced public offerings, while others like Summit Therapeutics and Regeneron have shared updates on their oncology portfolios and pipeline advancements. Additionally, companies like Viridian Therapeutics and Cargo Therapeutics have made announcements regarding public offerings and acquisitions.
Engagements: XXXXXX #
- X Week XXXXXX +56%
- X Month XXXXXXX -XX%
- X Months XXXXXXXXX +157%
- X Year XXXXXXXXX +40%
Mentions: XX #
- X Week XXX -XX%
- X Month XXX -XX%
- X Months XXXXX +41%
- X Year XXXXX +12%
Followers: XXXXX #
- X Week XXXXX +0.36%
- X Month XXXXX +3.30%
- X Months XXXXX +39%
- X Year XXXXX +64%
CreatorRank: XXXXXXX #
Social Influence
Social category influence countries XXXXX% stocks XXXXX% cryptocurrencies XXXX% finance XXXX% currencies XXXX%
Social topic influence $prax 3.27%, $asnd 3.27%, $kymr #25, kymera #9, announces 2.61%, $tara #46, $gpcr #10, $adct #5, $bhvn 1.96%, $nuvl XXXX%
Top accounts mentioned or mentioned by @aaronrosenblum5 @justiceforb_md @seedy19tron @saicharanaitha @karensmithfl @threadanddoc @rezfszubagoly @joserestonva @oncinvestor @andre_agtc @pencilvester999 @biopharmacaster @biotechport @senormargarita @jeremyj0916 @tuduni90782 @tallnfat @svarre001 @biohazard3737 @snupsnus
Top assets mentioned Praxis Precision Medicines, Inc. Common Stock (PRAX) Kymera Therapeutics, Inc. Common Stock (KYMR) Taraxa (TARA) ADC Therapeutics SA (ADCT) Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Nuvalent, Inc. Class A Common Stock (NUVL) Biogen Inc (BIIB) Dyne Therapeutics, Inc. Common Stock (DYN) Sarepta Therapeutics, Inc. (SRPT) Cogent Biosciences, Inc. Common Stock (COGT) Neurocrine Biosciences, Inc. (NBIX) United Therapeutics, Corp. (UTHR) Arrowhead Research Corporation (ARWR) Vera Therapeutics, Inc. Class A Common Stock (VERA) Ionis Pharmaceuticals, Inc. Common Stock (IONS) SATS (Ordinals) (SATS) Mirum Pharmaceuticals, Inc. Common Stock (MIRM) Wave Life Sciences Ltd. Ordinary Shares (WVE) Terns Pharmaceuticals, Inc. Common Stock (TERN) Royalty Pharma plc Class A Ordinary Shares (RPRX) Denali Therapeutics Inc. Common Stock (DNLI) Liquidia Corporation Common Stock (LQDA) Krystal Biotech, Inc. Common Stock (KRYS) Axsome Therapeutics, Inc (AXSM) Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) Akropolis (AKRO) Prothena Corporation plc Ordinary Shares (PRTA) CG Oncology, Inc. Common stock (CGON) Insmed, Inc. (INSM) uniQure N.V. (QURE) Avidity Biosciences, Inc. Common Stock (RNA) Veeva Systems, Inc. (VEEV) Dawn Protocol (DAWN) AltLayer (ALT) AstraZeneca PLC (AZN) IDEAYA Biosciences, Inc. Common Stock (IDYA) Xenon Pharmaceuticals Inc (XENE) Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX)
Top Social Posts
Top posts by engagements in the last XX hours
"$SATS frisky 🔥 Not a bio but it might be worth risking a trade"
X Link 2025-12-08T02:00Z 6154 followers, 1157 engagements
"@biopharmacaster Patience. People have to realize these amazing results $DYN. $SRPT should be toast on this news"
X Link 2025-12-08T11:46Z 6157 followers, 1004 engagements
"$ABOS Acumen Pharmaceuticals Highlights Enhanced Brain Delivery Technology for Oligomer-Selective Antibod. - ABOS BioPharmCatalyst"
X Link 2025-12-02T13:22Z 6154 followers, 1055 engagements
"@SaicharanAitha Yes"
X Link 2025-12-08T01:49Z 6154 followers, XXX engagements
"$MIRM Mirum Pharmaceuticals Enters into Definitive Agreement to Acquire Bluejay Therapeutics Expanding Global Leadership in Rare Disease BioPharmCatalyst"
X Link 2025-12-08T13:09Z 6157 followers, 1194 engagements
"Brief recap of my long tickets today. All sold with data spike today: $IMMX +11% 📈 $FULC +62% 📈 $DYN +15% 📈 $GPCR +150% 📈 * $WVE +158% 📈 $TERN +35% 📈 * Unfortunately sold a little too early. I'm not a fan of having too many stocks in my longterm port so I'm waiting for the financings and then picking out 1-2 gems. $GPCR is definitely one of them"
X Link 2025-12-08T20:45Z 6157 followers, 4927 engagements
"$RPRX $DNLI Denali Therapeutics and Royalty Pharma Announce $XXX Million Royalty Funding Agreement BioPharmCatalyst"
X Link 2025-12-04T12:17Z 6154 followers, 1556 engagements
"$KYMR Kymera Therapeutics Announces Proposed Public Offering BioPharmCatalyst"
X Link 2025-12-08T21:03Z 6157 followers, 2193 engagements
"$PRAX Praxis AES Wrap-up: Best-in-Class Potential Across Rare Pediatric and Adult Epilepsies BioPharmCatalyst"
X Link 2025-12-08T13:14Z 6157 followers, 1582 engagements
"$COGT I have added to my existing long-term position. I am deeply convinced that this stock is a candidate for a buyout that at least 2-3 big pharma will be fighting over. Thanks for the dips. I will continue to accumulate ✌🏻🤑"
X Link 2025-12-09T18:20Z 6157 followers, 9789 engagements
"$RGNX REGENXBIO Presents Positive Twelve-Month Pivotal Data from Phase I/II/III CAMPSIITE Trial of RGX-12. - RGNX BioPharmCatalyst"
X Link 2025-09-05T11:08Z 6155 followers, 1438 engagements
"$NBIX Neurocrine Biosciences Presents New Three-Year Data Demonstrating Sustained Clinical Benefits and Es. - NBIX BioPharmCatalyst"
X Link 2025-10-06T12:33Z 6153 followers, 3233 engagements
"$ASND Ascendis Submits Marketing Authorisation Application to the European Medicines Agency for TransCon. - ASND BioPharmCatalyst"
X Link 2025-10-08T20:02Z 6146 followers, 1730 engagements
"$KYMR Kymera Therapeutics Presents New Preclinical Data for KT-579 a First-in-Class Oral IRF5 Degrader. - KYMR BioPharmCatalyst"
X Link 2025-10-27T11:15Z 6156 followers, 1148 engagements
"$SLS SELLAS Life Sciences Group Announces Exercise of Existing Warrants Held by a Current Institutional I. - SLS BioPharmCatalyst"
X Link 2025-10-27T12:38Z 6147 followers, 1536 engagements
"$UTHR United Therapeutics Corporation Reports Record Third Quarter 2025 Financial Results - UTHR BioPharmCatalyst"
X Link 2025-10-29T10:33Z 6146 followers, 5557 engagements
"I took X new trading positions in $LQDA $KRYS and $AXSM. All X have earnings calls on Monday before market open"
X Link 2025-10-31T15:40Z 6146 followers, 8088 engagements
"$ARWR $KURA $ASND"
X Link 2025-10-31T19:39Z 6146 followers, 4819 engagements
"$MDGL delivered again solid numbers. Sold today my position @ 460$. I don't think this price can be maintained especially not in this market jmho"
X Link 2025-11-04T20:25Z 6146 followers, 4141 engagements
"$VERA Vera Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results - VERA BioPharmCatalyst"
X Link 2025-11-05T12:52Z 6146 followers, XXX engagements
"$VERA Vera Therapeutics Announces Positive ORIGIN Phase X Data for Atacicept in IgA Nephropathy Presented. - VERA BioPharmCatalyst"
X Link 2025-11-06T14:53Z 6146 followers, 1206 engagements
"$ASND New Pooled 3-Year Analysis Confirms Sustained Clinically Meaningful Improvements in Renal Function. - ASND BioPharmCatalyst"
X Link 2025-11-07T13:32Z 6146 followers, 1138 engagements
"$ADCT ADC Therapeutics Reports Third Quarter 2025 Financial Results and Provides Operational Update - ADCT BioPharmCatalyst"
X Link 2025-11-10T12:43Z 6151 followers, XXX engagements
"$NBIX #fail Neurocrine Biosciences Provides Update on Phase X Study of NBI-1070770 in Adults with Major Depressi. - NBIX BioPharmCatalyst"
X Link 2025-11-10T21:10Z 6152 followers, 10.7K engagements
"$QNCX +15% 📈 AH Quince Therapeutics Announces Positive iDSMB Review for eDSP in Pivotal Phase X NEAT Clinical Trial. - QNCX BioPharmCatalyst"
X Link 2025-11-10T21:12Z 6145 followers, 1064 engagements
"$PRTA Prothena Highlights Phase X Data for Coramitug (Formerly PRX004) Published in Circulation Official. - PRTA BioPharmCatalyst"
X Link 2025-11-11T14:14Z 6146 followers, 1928 engagements
"$BHVN Biohaven Announces Proposed Public Offering of Common Shares - BHVN BioPharmCatalyst"
X Link 2025-11-11T21:07Z 6145 followers, 2636 engagements
"$ASND Ascendis Pharma Reports Third Quarter 2025 Financial Results - ASND BioPharmCatalyst"
X Link 2025-11-12T21:01Z 6145 followers, 1130 engagements
"$CGON CG Oncology Reports Third Quarter 2025 Financial Results and Provides Business Updates - CGON BioPharmCatalyst"
X Link 2025-11-14T13:19Z 6153 followers, XXX engagements
"There is only one new 13-F that really interests me: DARWIN GLOBAL MANAGEMENT LTD $ABVX $INSM $UTHR $QURE"
X Link 2025-11-14T23:11Z 6152 followers, 33K engagements
"$NUVL Nuvalent Announces Positive Topline Pivotal Data from ALKOVE-1 Clinical Trial of Neladalkib for TKI. - NUVL BioPharmCatalyst"
X Link 2025-11-17T11:32Z 6146 followers, 1832 engagements
"Added a new position $BHVN here. Set and forget"
X Link 2025-11-17T19:31Z 6145 followers, 13.9K engagements
"$NUVL Nuvalent Announces Public Offering of Common Stock - NUVL BioPharmCatalyst"
X Link 2025-11-17T21:02Z 6146 followers, 1157 engagements
"$ASND Results of Pivotal ApproaCH Trial of TransCon CNP (Navepegritide) in Children with Achondroplasia P. - ASND BioPharmCatalyst"
X Link 2025-11-17T21:04Z 6146 followers, 3669 engagements
"$TARA Conference call and live webcast at 8:30 a.m. ET on Wednesday November XX 2025 📌 Protara Therapeutics to Host Conference Call and Webcast to Review New Interim Data from Phase X STA. - TARA BioPharmCatalyst"
X Link 2025-11-18T21:32Z 6151 followers, 2309 engagements
"$BHVN UP 📈"
X Link 2025-11-18T23:14Z 6145 followers, 6863 engagements
"$NUVL @ $XXXXXX Nuvalent Announces Pricing of Public Offering of Common Stock"
X Link 2025-11-19T09:04Z 6146 followers, 1241 engagements
"$RNA Avidity Biosciences Announces U.S. Managed Access Program (MAP) for Investigational Therapy del-zota. - RNA BioPharmCatalyst"
X Link 2025-11-19T14:15Z 6153 followers, 1632 engagements
"$VEEV $RHHBF Veeva Announces Expanded Partnership with Roche"
X Link 2025-11-24T12:15Z 6151 followers, 1163 engagements
"$BIIB Biogen and Dayra Therapeutics Announce Research Collaboration to Discover and Develop Oral Macrocycl. - BIIB BioPharmCatalyst"
X Link 2025-11-24T12:31Z 6150 followers, XXX engagements
"$ARWR $SRPT Arrowhead Pharmaceuticals Earns $XXX Million Milestone Payment from Sarepta Therapeutics - SRPT BioPharmCatalyst"
X Link 2025-11-24T12:53Z 6150 followers, 1518 engagements
"$DAWN Day One Announces Three Year Follow-Up Data From OJEMDA (tovorafenib) Phase X FIREFLY-1 Trial at th. - DAWN BioPharmCatalyst"
X Link 2025-11-24T13:18Z 6150 followers, 1399 engagements
"$BIIB Eisai Completes Rolling Submission to U.S. FDA for LEQEMBI IQLIK (lecanemab-irmb) Supplemental Bio. - BIIB BioPharmCatalyst"
X Link 2025-11-25T12:32Z 6151 followers, 1142 engagements
"$QTTB Q32 Bio Sells Complement Inhibitor ADX-097"
X Link 2025-12-01T12:03Z 6152 followers, 5014 engagements
"$IONS Ionis receives U.S. FDA Breakthrough Therapy designation for olezarsen for severe hypertriglyceridem. - IONS BioPharmCatalyst"
X Link 2025-12-01T12:05Z 6146 followers, 1066 engagements
"$ALT Altimmune Announces CEO Transition and Succession Plan - ALT BioPharmCatalyst"
X Link 2025-12-01T12:30Z 6144 followers, 1454 engagements
"$TARA Protara Therapeutics to Host Conference Call and Webcast to Review New Interim Data from Phase X ADV. - TARA BioPharmCatalyst"
X Link 2025-12-01T21:29Z 6151 followers, 2055 engagements
"$FENC Fennec Pharmaceuticals Announces Positive Topline Results From Investigator-Initiated Clinical Study. - FENC BioPharmCatalyst"
X Link 2025-12-02T12:14Z 6155 followers, XXX engagements
"$IONS Ionis receives U.S. FDA Breakthrough Therapy designation for zilganersen for Alexander disease (AxD) - IONS BioPharmCatalyst"
X Link 2025-12-02T12:15Z 6146 followers, 1070 engagements
"$BAYRY Bayer Starts New Phase III Study with Mirena for the Treatment of Nonatypical Endometrial Hyperplas. - BAYRY BioPharmCatalyst"
X Link 2025-12-02T13:32Z 6146 followers, 1012 engagements
"$AZN Baxdrostat New Drug Application accepted under FDA Priority Review in the US for patients with hard-. - AZN BioPharmCatalyst @avidresearch"
X Link 2025-12-02T14:18Z 6153 followers, 1616 engagements
"$ADCT Company to host corporate webcast to share updated data on December X 2025 📌 ADC Therapeutics to Provide Update on LOTIS-7 Clinical Trial - ADCT BioPharmCatalyst"
X Link 2025-12-02T21:29Z 6151 followers, 1483 engagements
"$BIIB New Data Presented at the Clinical Trials on Alzheimer's Disease (CTAD) Conference 2025 Confirms Pha. - BIIB BioPharmCatalyst"
X Link 2025-12-02T21:41Z 6150 followers, 1279 engagements
"$ADCT ADC Therapeutics Announces Updated Data from LOTIS-7 Phase 1b Clinical Trial of ZYNLONTA in Combina. - ADCT BioPharmCatalyst"
X Link 2025-12-03T12:39Z 6151 followers, 1443 engagements
"$PRAX Praxis Precision Medicines Announces Positive Pre-NDA Meeting with FDA for Ulixacaltamide in Essential Tremor BioPharmCatalyst"
X Link 2025-12-04T21:04Z 6150 followers, 7592 engagements
"$PRAX Praxis Precision Medicines Announces Positive Results from EMBOLD Study for Relutrigine in SCN2A and SCN8A Developmental and Epileptic Encephalopathies BioPharmCatalyst"
X Link 2025-12-04T21:15Z 6146 followers, 2873 engagements
"$PRAX baby 🚀"
X Link 2025-12-04T21:34Z 6146 followers, 4570 engagements
"$IDYA IDE034 a Bispecific ADC Licensed by Biocytogen to IDEAYA Receives FDA IND Clearance BioPharmCatalyst"
X Link 2025-12-05T00:05Z 6151 followers, 1711 engagements
"$XENE Xenon Showcases New 48-Month Azetukalner OLE Study Data in Epilepsy at AES 2025 BioPharmCatalyst"
X Link 2025-12-05T14:19Z 6151 followers, XXX engagements
"$KYMR Kymera Therapeutics to Announce KT-621 BroADen Phase 1b Atopic Dermatitis Trial Results on December X 2025 BioPharmCatalyst @seedy19tron"
X Link 2025-12-06T03:20Z 6155 followers, 2429 engagements
"$SLS SELLAS Life Sciences Presents Positive Phase X Data of SLS009 in Combination with AZA/VEN in Relapsed/Refractory AML-MR at ASH 2025 BioPharmCatalyst"
X Link 2025-12-07T23:05Z 6155 followers, 2541 engagements
"$KYMR Kymera Therapeutics Announces Positive Results from BroADen Phase 1b Clinical Trial of KT-621 a First-in-Class Oral STAT6 Degrader in Patients with Moderate to Severe Atopic Dermatitis BioPharmCatalyst"
X Link 2025-12-08T12:04Z 6155 followers, 1577 engagements
"$RXRX Positive Phase 1b/2 Results from Ongoing REC-4881 TUPELO Trial Demonstrate Rapid and Durable Reductions in Polyp Burden in Familial Adenomatous Polyposis (FAP) at XX Weeks"
X Link 2025-12-08T12:33Z 6153 followers, 1116 engagements
"$RGNX REGENXBIO Announces FDA Review Extension of BLA for RGX-121 to Treat Patients with MPS II"
X Link 2025-08-18T21:03Z 6154 followers, 2773 engagements
"$TARA Protara Therapeutics Announces Positive Interim Results Demonstrating Robust Responses in the Ongoin. - TARA BioPharmCatalyst"
X Link 2025-11-19T13:08Z 6154 followers, 2487 engagements
"$TARA Protara Announces Proposed Public Offering BioPharmCatalyst"
X Link 2025-12-04T21:26Z 6154 followers, 1075 engagements
"$SABS SAB BIO to Present Data Showcasing Progress in the Development of SAB-142 at the Asian Conference on Innovative Therapies for Diabetes Management BioPharmCatalyst"
X Link 2025-12-08T13:11Z 6157 followers, 1230 engagements
"@lame_karma Congrats. Now that the binaries are done it's time to see who has the most buyout potential. Not an easy task but I see $GPCR at the top of the list. $COGT too. And I agree that $FULC also belong in the inner circle. Too many good names at the moment"
X Link 2025-12-08T23:35Z 6157 followers, XXX engagements
"$LXEO Added today new trading position for data event soon"
X Link 2025-12-09T18:37Z 6157 followers, 2761 engagements